-
0
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-11-30 19:00:00
Did you know that adding a CDK 4/6 inhibitor to adjuvant endocrine therapy improves overall outcomes in HR-positive/HER2-negative early breast cancer?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Hypertension
281
global
1
1.0
9
1.0
1.0
Roundtable
0
1
Cardiology2023-11-29 19:00:00
Renal denervation is approved. Which patients are likely to benefit?
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Breast Cancer
840
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-11-20 19:00:00
Do you consult with the multidisciplinary team (MDT) when making treatment decisions for patients with hormone receptor (HR)-positive/HER2-negative early breast cancer (EBC)?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Atrial Fibrillation
390
global
1
0.5
9
0.5
2
0.5
3
0.5
0.5
Roundtable
0
1
Cardiology2023-11-16 19:00:00
Why target factor XI/XIa? Experts discuss the rationale, mechanism, and the latest phase 2 data.
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Breast Cancer
840
global
1
0.5
9
0.5
2
0.5
3
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-11-16 19:00:00
What strategies are you using to individualize treatment of HR+/HER2- early breast cancer?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Melanoma
65
global
1
1.0
9
1.0
1.0
Clinical Review
0
1
Hematology-Oncology2023-11-15 19:00:00
Are you familiar with how to incorporate lymphocyte-activation gene 3 (LAG-3) inhibition into the management of metastatic melanoma? Find out more here!
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
0
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-11-30 19:00:00
Did you know that adding a CDK 4/6 inhibitor to adjuvant endocrine therapy improves overall outcomes in HR-positive/HER2-negative early breast cancer?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Hypertension
281
global
1
1.0
9
1.0
1.0
Roundtable
0
1
Cardiology2023-11-29 19:00:00
Renal denervation is approved. Which patients are likely to benefit?
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Breast Cancer
840
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-11-20 19:00:00
Do you consult with the multidisciplinary team (MDT) when making treatment decisions for patients with hormone receptor (HR)-positive/HER2-negative early breast cancer (EBC)?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Atrial Fibrillation
390
global
1
0.5
9
0.5
2
0.5
3
0.5
0.5
Roundtable
0
1
Cardiology2023-11-16 19:00:00
Why target factor XI/XIa? Experts discuss the rationale, mechanism, and the latest phase 2 data.
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Breast Cancer
840
global
1
0.5
9
0.5
2
0.5
3
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-11-16 19:00:00
What strategies are you using to individualize treatment of HR+/HER2- early breast cancer?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Atrial Fibrillation
390
global
1
0.25
9
0.25
2
0.25
8
0.25
0.25
Clinical Brief
0
2
Cardiology2023-11-17 00:00:00
The current study assesses the risk for recurrent atrial fibrillation after transient atrial fibrillation and during hospitalization.
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Melanoma
65
global
1
1.0
9
1.0
1.0
Clinical Review
0
1
Hematology-Oncology2023-11-15 19:00:00
Are you familiar with how to incorporate lymphocyte-activation gene 3 (LAG-3) inhibition into the management of metastatic melanoma? Find out more here!
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
0
global
1
0.25
9
0.25
2
0.25
8
0.25
0.25
Clinical Brief
0
2
Family Medicine/Primary Care2023-11-15 00:00:00
A new study examines how continuity of care with a single primary care provider can affect rates of emergency department use after surgery.
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Breast Cancer
840
global
1
0.25
9
0.25
0.25
Clinical Review
0
1
Hematology-Oncology2023-11-15 00:00:00
Do you know how to identify patients with HR-positive/HER2-negative early breast cancer who have a high risk for recurrence?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Gastroesophageal Reflux Disease
3032531
global
1
1.0
9
1.0
2
1.0
3
1.0
1.0
Roundtable
0
1
Gastroenterology2023-11-06 19:00:00
Are you up to date on the latest treatment for patients with gastroesophageal reflux disease (GERD)?
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Skin Cancer
56
global
1
1.25
9
1.25
1.25
Roundtable
0
1
Hematology-Oncology2023-11-02 20:00:00
How well do you personalize treatment for patients with nonmelanoma skin cancer?
1.25ABIM MOC
1.25CME/CE
75MIN
Save
-
Gastroesophageal Reflux Disease
3032531
global
1
0.25
9
0.25
2
0.25
3
0.25
8
0.25
0.25
Clinical Brief
0
1
Gastroenterology2023-11-03 00:00:00
A new study characterizes risk for esophageal adenocarcinoma based on findings from esophagogastroduodenoscopy.
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Cardiomyopathy
342
global
1
1.0
9
1.0
2
1.0
3
1.0
1.0
Roundtable
0
1
Cardiology2023-10-30 20:00:00
Play along in this engaging game show educational program on hypertrophic cardiomyopathy to test your knowledge and learn all about this topic!
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Influenza
1226
global
1
0.5
9
0.5
2
0.5
3
0.5
8
0.5
0.5
Clinical Brief
0
1
Family Medicine/Primary Care2023-10-26 00:00:00
Learn about recent findings in arthritis prevalence, obesity drug-birth control pill interactions, and childhood flu vaccinations.
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Lung Cancer
5000186
global
1
1.25
9
1.25
1.25
Roundtable
0
1
Pathology & Lab Medicine2023-10-23 20:00:00
Do you know the best way to evaluate patients with non-small cell lung cancer (NSCLC) for driver mutations?
1.25ABIM MOC
1.25CME/CE
75MIN
Save
-
Skin Cancer
56
global
1
1.0
9
1.0
1.0
Clinical Case
0
1
Hematology-Oncology2023-10-22 20:00:00
How would you treat these patients presenting with skin cancer?
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Head and Neck Cancer
3004984
global
1
1.0
9
1.0
2
1.0
3
1.0
1.0
Roundtable
0
1
Hematology-Oncology2023-10-18 20:00:00
Do you know the best management for your patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN)?
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Endometrial Cancer
3003432
global
1
0.25
9
0.25
0.25
Clinical Review
0
1
Hematology-Oncology2023-10-13 00:00:00
Did you know that immunotherapies demonstrate durable efficacy in patients with mismatch repair deficiency (dMMR) across tumor types?
0.25ABIM MOC
0.25CME/CE
15MIN
Save